Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 10/20 | 0.42 |
| ▸ | DRD5 | P21918 | 9/20 | 0.42 |
| ▸ | DRD2 | P14416 | 9/20 | 0.42 |
| ▸ | DRD3 | P35462 | 8/20 | 0.42 |
| ▸ | DRD4 | P21917 | 7/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resorcinol SCHEMBL7718048 | 1.00 | TSHR (0.50) | TSHRCA12ALDH1A1CA2LMNA | |
| Resorcinol SCHEMBL7560004 | 0.87 | TSHR (0.41) | TSHRCA12ALDH1A1CA2LMNA | |
| Resorcinol SCHEMBL7561949 | 0.81 | TSHR (0.46) | TSHRCA12ALDH1A1CA2LMNA | |
| Resorcinol SCHEMBL7559136 | 0.81 | TSHR (0.46) | TSHRCA12ALDH1A1CA2LMNA | |
| Resorcinol SCHEMBL5703385 | 0.81 | CA12 (0.71) | TSHRCA12ALDH1A1CA2LMNA | |
| Resorcinol SCHEMBL4046401 | 0.81 | CA12 (0.71) | TSHRCA12ALDH1A1CA2LMNA | |
| Resorcinol SCHEMBL27494556 | 0.81 | CA12 (0.71) | TSHRCA12ALDH1A1CA2LMNA | |
| Phenol SCHEMBL27877234 | 0.77 | TSHR (0.68) | TSHRCA12ALDH1A1CA2CA9 | |
| Phenol SCHEMBL1151187 | 0.72 | TSHR (0.60) | TSHRCA12ALDH1A1CA2CA9 | |
| Resorcinol SCHEMBL3094520 | 0.72 | ALDH1A1 (0.63) | TSHRCA12ALDH1A1CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384113-B1 | POLYMER STABILIZER; LOW VOLATILITY; WEATHERABILITY; YELLOWING RESISTANCE | CYTEC TECHNOLOGY CORP. | 2002-05-07 | — | — | US | disclosed |
| US-20020028937-A1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC TECHNOLOGY CORP. | 2002-03-07 | — | — | US | disclosed |
| US-6297377-B1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | CYTEC TECHNOLOGY CORPORATION | 2001-10-02 | — | — | US | disclosed |
| EP-1089987-A1 | BENZOCYCLE-SUBSTITUTED TRIAZINE AND PYRIMIDINE ULTRAVIOLET LIGHT ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067225-A1 | BENZOCYCLE-SUBSTITUTED TRIAZINE AND PYRIMIDINE ULTRAVIOLET LIGHT ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028937-A1 | Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers | ERCC5, ERCC4, ERCC2 | TSHR 1732/4885CA12 4508/4885ALDH1A1 979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.